Prevalence of clinical signs of possible serious bacterial infection and mortality associated with them from population-based surveillance of young infants from birth to 2 months of age

Community-based data on the prevalence of clinical signs of possible serious bacterial infection (PSBI) and the mortality associated with them are scarce. The aim was to examine the prevalence for each sign of infection and mortality associated with infants in the first two months of life, using com...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2021-02, Vol.16 (2), p.e0247457-e0247457
Hauptverfasser: Puri, Dhruv, Nisar, Yasir Bin, Tshefu, Antoinette, Longombe, Adrien Lokangaka, Esamai, Fabian, Marete, Irene, Ayede, Adejumoke Idowu, Adejuyigbe, Ebunoluwa A, Wammanda, Robinson D, Qazi, Shamim Ahmad, Bahl, Rajiv
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0247457
container_issue 2
container_start_page e0247457
container_title PloS one
container_volume 16
creator Puri, Dhruv
Nisar, Yasir Bin
Tshefu, Antoinette
Longombe, Adrien Lokangaka
Esamai, Fabian
Marete, Irene
Ayede, Adejumoke Idowu
Adejuyigbe, Ebunoluwa A
Wammanda, Robinson D
Qazi, Shamim Ahmad
Bahl, Rajiv
description Community-based data on the prevalence of clinical signs of possible serious bacterial infection (PSBI) and the mortality associated with them are scarce. The aim was to examine the prevalence for each sign of infection and mortality associated with infants in the first two months of life, using community surveillance through community health workers (CHW). We used population-based surveillance data of infants up to two months of age from the African Neonatal Sepsis Trial (AFRINEST). In this study, CHWs visited infants up to 10 times during the first two months of life at five sites in three sub-Saharan African countries. CHW assessed the infant for signs of infection (local or systemic) and referred infants who presented with any sign of infection to a health facility. We used a longitudinal analysis to calculate the risk of death associated with the presence of a sign of infection at the time of the visit until the subsequent visit. During the first two months of their life, CHWs visited 84,759 live-born infants at least twice. In 11,089 infants (13.1%), one or more signs of infection were identified, of which 237 (2.1%) died. A sign of infection was detected at 2.1% of total visits. In 52% of visits, infants had one or more sign of systemic infection, while 25% had fast breathing in 7-59 days period and 23% had a local infection. All signs of infection, including multiple signs, were more frequently seen in the first week of life. The risk of mortality was very low (0.2%) for local infections and fast breathing in 7-59 days old, it was low for fast breathing 0-6 days old (0.6%), high body temperature (0.7%) and severe chest indrawing (1.0%), moderate for low body temperature (4.9%) and stopped feeding well/not able to feed at all (5.0%) and high for movement only when stimulated or no movement at all (10%) and multiple signs of systemic infection (15.5%). The risk of death associated with most clinical signs was higher (1.5 to 9 times) in the first week of life than at later age, except for low body temperature (4 times lower) as well as high body temperature (2 times lower). Signs of infections are common in the first two months of life. The mortality risk differs with clinical signs and can be grouped as very low (local infections, fast breathing 7-59 days), low (fever, severe chest indrawing and fast breathing 0-6 days), moderate (low body temperature and stopped feeding well/not able to feed at all) and high (for movements only on stimulation or no
doi_str_mv 10.1371/journal.pone.0247457
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2492989950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A652924360</galeid><doaj_id>oai_doaj_org_article_87b2e781cea64fdb9ea0e7d5d7d83db3</doaj_id><sourcerecordid>A652924360</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-98a9975f6ad41e9639819313d1ff2db0bb2baea5666a129c8f80caf701129a053</originalsourceid><addsrcrecordid>eNqNk9tu1DAQhiMEolB4AwSRkBBc7OI4iRPfIFUVh0qVijjdWhN7knXl2IvtFPpovB1ON626qBcoF3HG3_zj_J7JsmcFWRdlU7w9d5O3YNZbZ3FNaNVUdXMve1Twkq4YJeX9W-uD7HEI54TUZcvYw-ygLBllhJNH2Z_PHi_AoJWYuz6XRlstweRBDzbMka0LQXcG84BeuynkHciYlonRtkcZtbM5WJWPzkcwOl7mEIKTGiKq_JeOmzxucMx778Yktp0MzCmrDkLaD5O_QG0MLPUv3WSHWRhsDLucTvtZw-U0lbBxc3UqGPBJ9qAHE_Dp8j7Mvn94_-340-r07OPJ8dHpSjJO44q3wHlT9wxUVSBnJW-TLUWpir6nqiNdRztAqBljUFAu274lEvqGFOkLkmOH2Yud7ta4IBbXg6AVp7zlvCaJONkRysG52Ho9gr8UDrS4Cjg_CPBRS4OibTqKTVtIBFb1quMIBBtVq0a1perKpPVuqTZ1IyqJNnowe6L7O1ZvxOAuRMNJRQlNAq8XAe9-ThiiGHWQOFuM6frmc5dVzVoy13r5D3r33y3UkNpEpKtxqa6cRcURqymnVclman0HlR6Fo5apRXud4nsJb_YSEhPxdxxgCkGcfP3y_-zZj3321S12g2BSyzgzzU0X9sFqB0qfWtxjf2NyQcQ8YdduiHnCxDJhKe357Qu6SboeqfIv1U0liQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2492989950</pqid></control><display><type>article</type><title>Prevalence of clinical signs of possible serious bacterial infection and mortality associated with them from population-based surveillance of young infants from birth to 2 months of age</title><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Puri, Dhruv ; Nisar, Yasir Bin ; Tshefu, Antoinette ; Longombe, Adrien Lokangaka ; Esamai, Fabian ; Marete, Irene ; Ayede, Adejumoke Idowu ; Adejuyigbe, Ebunoluwa A ; Wammanda, Robinson D ; Qazi, Shamim Ahmad ; Bahl, Rajiv</creator><contributor>Marotta, Claudia</contributor><creatorcontrib>Puri, Dhruv ; Nisar, Yasir Bin ; Tshefu, Antoinette ; Longombe, Adrien Lokangaka ; Esamai, Fabian ; Marete, Irene ; Ayede, Adejumoke Idowu ; Adejuyigbe, Ebunoluwa A ; Wammanda, Robinson D ; Qazi, Shamim Ahmad ; Bahl, Rajiv ; Marotta, Claudia</creatorcontrib><description>Community-based data on the prevalence of clinical signs of possible serious bacterial infection (PSBI) and the mortality associated with them are scarce. The aim was to examine the prevalence for each sign of infection and mortality associated with infants in the first two months of life, using community surveillance through community health workers (CHW). We used population-based surveillance data of infants up to two months of age from the African Neonatal Sepsis Trial (AFRINEST). In this study, CHWs visited infants up to 10 times during the first two months of life at five sites in three sub-Saharan African countries. CHW assessed the infant for signs of infection (local or systemic) and referred infants who presented with any sign of infection to a health facility. We used a longitudinal analysis to calculate the risk of death associated with the presence of a sign of infection at the time of the visit until the subsequent visit. During the first two months of their life, CHWs visited 84,759 live-born infants at least twice. In 11,089 infants (13.1%), one or more signs of infection were identified, of which 237 (2.1%) died. A sign of infection was detected at 2.1% of total visits. In 52% of visits, infants had one or more sign of systemic infection, while 25% had fast breathing in 7-59 days period and 23% had a local infection. All signs of infection, including multiple signs, were more frequently seen in the first week of life. The risk of mortality was very low (0.2%) for local infections and fast breathing in 7-59 days old, it was low for fast breathing 0-6 days old (0.6%), high body temperature (0.7%) and severe chest indrawing (1.0%), moderate for low body temperature (4.9%) and stopped feeding well/not able to feed at all (5.0%) and high for movement only when stimulated or no movement at all (10%) and multiple signs of systemic infection (15.5%). The risk of death associated with most clinical signs was higher (1.5 to 9 times) in the first week of life than at later age, except for low body temperature (4 times lower) as well as high body temperature (2 times lower). Signs of infections are common in the first two months of life. The mortality risk differs with clinical signs and can be grouped as very low (local infections, fast breathing 7-59 days), low (fever, severe chest indrawing and fast breathing 0-6 days), moderate (low body temperature and stopped feeding well/not able to feed at all) and high (for movements only on stimulation or no movements at all and multiple signs of infection). New treatment strategies that consider differential mortality risk could be developed and evaluated based on these findings. The trial was registered with Australian New Zealand Clinical Trials Registry under ID ACTRN 12610000286044.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0247457</identifier><identifier>PMID: 33626090</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adolescents ; Age ; Aging ; Bacterial diseases ; Bacterial infections ; Biology and Life Sciences ; Body temperature ; Children ; Childrens health ; Data analysis ; Demographic aspects ; Diagnosis ; Direct reduction ; Editing ; Fatalities ; Fever ; Health risks ; Health surveillance ; Hospitals ; Infants ; Infections ; Medicine ; Medicine and Health Sciences ; Meta-analysis ; Methodology ; Mortality ; Mortality risk ; Neonates ; Newborn babies ; Patient outcomes ; Pediatrics ; People and Places ; Public health ; Sepsis ; Signs</subject><ispartof>PloS one, 2021-02, Vol.16 (2), p.e0247457-e0247457</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 World Health Organization. License: http://creativecommons.org/licenses/by/3.0/igo/ (the “License”) e Public Library of Science. This is an open access article distributed under the Creative Commons Attribution IGO License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 World Health Organization. Licensee Public Library of Science 2021 World Health Organization. Licensee Public Library of Science</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-98a9975f6ad41e9639819313d1ff2db0bb2baea5666a129c8f80caf701129a053</citedby><cites>FETCH-LOGICAL-c692t-98a9975f6ad41e9639819313d1ff2db0bb2baea5666a129c8f80caf701129a053</cites><orcidid>0000-0002-9720-5699</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904202/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904202/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33626090$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Marotta, Claudia</contributor><creatorcontrib>Puri, Dhruv</creatorcontrib><creatorcontrib>Nisar, Yasir Bin</creatorcontrib><creatorcontrib>Tshefu, Antoinette</creatorcontrib><creatorcontrib>Longombe, Adrien Lokangaka</creatorcontrib><creatorcontrib>Esamai, Fabian</creatorcontrib><creatorcontrib>Marete, Irene</creatorcontrib><creatorcontrib>Ayede, Adejumoke Idowu</creatorcontrib><creatorcontrib>Adejuyigbe, Ebunoluwa A</creatorcontrib><creatorcontrib>Wammanda, Robinson D</creatorcontrib><creatorcontrib>Qazi, Shamim Ahmad</creatorcontrib><creatorcontrib>Bahl, Rajiv</creatorcontrib><title>Prevalence of clinical signs of possible serious bacterial infection and mortality associated with them from population-based surveillance of young infants from birth to 2 months of age</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Community-based data on the prevalence of clinical signs of possible serious bacterial infection (PSBI) and the mortality associated with them are scarce. The aim was to examine the prevalence for each sign of infection and mortality associated with infants in the first two months of life, using community surveillance through community health workers (CHW). We used population-based surveillance data of infants up to two months of age from the African Neonatal Sepsis Trial (AFRINEST). In this study, CHWs visited infants up to 10 times during the first two months of life at five sites in three sub-Saharan African countries. CHW assessed the infant for signs of infection (local or systemic) and referred infants who presented with any sign of infection to a health facility. We used a longitudinal analysis to calculate the risk of death associated with the presence of a sign of infection at the time of the visit until the subsequent visit. During the first two months of their life, CHWs visited 84,759 live-born infants at least twice. In 11,089 infants (13.1%), one or more signs of infection were identified, of which 237 (2.1%) died. A sign of infection was detected at 2.1% of total visits. In 52% of visits, infants had one or more sign of systemic infection, while 25% had fast breathing in 7-59 days period and 23% had a local infection. All signs of infection, including multiple signs, were more frequently seen in the first week of life. The risk of mortality was very low (0.2%) for local infections and fast breathing in 7-59 days old, it was low for fast breathing 0-6 days old (0.6%), high body temperature (0.7%) and severe chest indrawing (1.0%), moderate for low body temperature (4.9%) and stopped feeding well/not able to feed at all (5.0%) and high for movement only when stimulated or no movement at all (10%) and multiple signs of systemic infection (15.5%). The risk of death associated with most clinical signs was higher (1.5 to 9 times) in the first week of life than at later age, except for low body temperature (4 times lower) as well as high body temperature (2 times lower). Signs of infections are common in the first two months of life. The mortality risk differs with clinical signs and can be grouped as very low (local infections, fast breathing 7-59 days), low (fever, severe chest indrawing and fast breathing 0-6 days), moderate (low body temperature and stopped feeding well/not able to feed at all) and high (for movements only on stimulation or no movements at all and multiple signs of infection). New treatment strategies that consider differential mortality risk could be developed and evaluated based on these findings. The trial was registered with Australian New Zealand Clinical Trials Registry under ID ACTRN 12610000286044.</description><subject>Adolescents</subject><subject>Age</subject><subject>Aging</subject><subject>Bacterial diseases</subject><subject>Bacterial infections</subject><subject>Biology and Life Sciences</subject><subject>Body temperature</subject><subject>Children</subject><subject>Childrens health</subject><subject>Data analysis</subject><subject>Demographic aspects</subject><subject>Diagnosis</subject><subject>Direct reduction</subject><subject>Editing</subject><subject>Fatalities</subject><subject>Fever</subject><subject>Health risks</subject><subject>Health surveillance</subject><subject>Hospitals</subject><subject>Infants</subject><subject>Infections</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Meta-analysis</subject><subject>Methodology</subject><subject>Mortality</subject><subject>Mortality risk</subject><subject>Neonates</subject><subject>Newborn babies</subject><subject>Patient outcomes</subject><subject>Pediatrics</subject><subject>People and Places</subject><subject>Public health</subject><subject>Sepsis</subject><subject>Signs</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk9tu1DAQhiMEolB4AwSRkBBc7OI4iRPfIFUVh0qVijjdWhN7knXl2IvtFPpovB1ON626qBcoF3HG3_zj_J7JsmcFWRdlU7w9d5O3YNZbZ3FNaNVUdXMve1Twkq4YJeX9W-uD7HEI54TUZcvYw-ygLBllhJNH2Z_PHi_AoJWYuz6XRlstweRBDzbMka0LQXcG84BeuynkHciYlonRtkcZtbM5WJWPzkcwOl7mEIKTGiKq_JeOmzxucMx778Yktp0MzCmrDkLaD5O_QG0MLPUv3WSHWRhsDLucTvtZw-U0lbBxc3UqGPBJ9qAHE_Dp8j7Mvn94_-340-r07OPJ8dHpSjJO44q3wHlT9wxUVSBnJW-TLUWpir6nqiNdRztAqBljUFAu274lEvqGFOkLkmOH2Yud7ta4IBbXg6AVp7zlvCaJONkRysG52Ho9gr8UDrS4Cjg_CPBRS4OibTqKTVtIBFb1quMIBBtVq0a1perKpPVuqTZ1IyqJNnowe6L7O1ZvxOAuRMNJRQlNAq8XAe9-ThiiGHWQOFuM6frmc5dVzVoy13r5D3r33y3UkNpEpKtxqa6cRcURqymnVclman0HlR6Fo5apRXud4nsJb_YSEhPxdxxgCkGcfP3y_-zZj3321S12g2BSyzgzzU0X9sFqB0qfWtxjf2NyQcQ8YdduiHnCxDJhKe357Qu6SboeqfIv1U0liQ</recordid><startdate>20210224</startdate><enddate>20210224</enddate><creator>Puri, Dhruv</creator><creator>Nisar, Yasir Bin</creator><creator>Tshefu, Antoinette</creator><creator>Longombe, Adrien Lokangaka</creator><creator>Esamai, Fabian</creator><creator>Marete, Irene</creator><creator>Ayede, Adejumoke Idowu</creator><creator>Adejuyigbe, Ebunoluwa A</creator><creator>Wammanda, Robinson D</creator><creator>Qazi, Shamim Ahmad</creator><creator>Bahl, Rajiv</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9720-5699</orcidid></search><sort><creationdate>20210224</creationdate><title>Prevalence of clinical signs of possible serious bacterial infection and mortality associated with them from population-based surveillance of young infants from birth to 2 months of age</title><author>Puri, Dhruv ; Nisar, Yasir Bin ; Tshefu, Antoinette ; Longombe, Adrien Lokangaka ; Esamai, Fabian ; Marete, Irene ; Ayede, Adejumoke Idowu ; Adejuyigbe, Ebunoluwa A ; Wammanda, Robinson D ; Qazi, Shamim Ahmad ; Bahl, Rajiv</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-98a9975f6ad41e9639819313d1ff2db0bb2baea5666a129c8f80caf701129a053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adolescents</topic><topic>Age</topic><topic>Aging</topic><topic>Bacterial diseases</topic><topic>Bacterial infections</topic><topic>Biology and Life Sciences</topic><topic>Body temperature</topic><topic>Children</topic><topic>Childrens health</topic><topic>Data analysis</topic><topic>Demographic aspects</topic><topic>Diagnosis</topic><topic>Direct reduction</topic><topic>Editing</topic><topic>Fatalities</topic><topic>Fever</topic><topic>Health risks</topic><topic>Health surveillance</topic><topic>Hospitals</topic><topic>Infants</topic><topic>Infections</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Meta-analysis</topic><topic>Methodology</topic><topic>Mortality</topic><topic>Mortality risk</topic><topic>Neonates</topic><topic>Newborn babies</topic><topic>Patient outcomes</topic><topic>Pediatrics</topic><topic>People and Places</topic><topic>Public health</topic><topic>Sepsis</topic><topic>Signs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Puri, Dhruv</creatorcontrib><creatorcontrib>Nisar, Yasir Bin</creatorcontrib><creatorcontrib>Tshefu, Antoinette</creatorcontrib><creatorcontrib>Longombe, Adrien Lokangaka</creatorcontrib><creatorcontrib>Esamai, Fabian</creatorcontrib><creatorcontrib>Marete, Irene</creatorcontrib><creatorcontrib>Ayede, Adejumoke Idowu</creatorcontrib><creatorcontrib>Adejuyigbe, Ebunoluwa A</creatorcontrib><creatorcontrib>Wammanda, Robinson D</creatorcontrib><creatorcontrib>Qazi, Shamim Ahmad</creatorcontrib><creatorcontrib>Bahl, Rajiv</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Puri, Dhruv</au><au>Nisar, Yasir Bin</au><au>Tshefu, Antoinette</au><au>Longombe, Adrien Lokangaka</au><au>Esamai, Fabian</au><au>Marete, Irene</au><au>Ayede, Adejumoke Idowu</au><au>Adejuyigbe, Ebunoluwa A</au><au>Wammanda, Robinson D</au><au>Qazi, Shamim Ahmad</au><au>Bahl, Rajiv</au><au>Marotta, Claudia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of clinical signs of possible serious bacterial infection and mortality associated with them from population-based surveillance of young infants from birth to 2 months of age</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2021-02-24</date><risdate>2021</risdate><volume>16</volume><issue>2</issue><spage>e0247457</spage><epage>e0247457</epage><pages>e0247457-e0247457</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Community-based data on the prevalence of clinical signs of possible serious bacterial infection (PSBI) and the mortality associated with them are scarce. The aim was to examine the prevalence for each sign of infection and mortality associated with infants in the first two months of life, using community surveillance through community health workers (CHW). We used population-based surveillance data of infants up to two months of age from the African Neonatal Sepsis Trial (AFRINEST). In this study, CHWs visited infants up to 10 times during the first two months of life at five sites in three sub-Saharan African countries. CHW assessed the infant for signs of infection (local or systemic) and referred infants who presented with any sign of infection to a health facility. We used a longitudinal analysis to calculate the risk of death associated with the presence of a sign of infection at the time of the visit until the subsequent visit. During the first two months of their life, CHWs visited 84,759 live-born infants at least twice. In 11,089 infants (13.1%), one or more signs of infection were identified, of which 237 (2.1%) died. A sign of infection was detected at 2.1% of total visits. In 52% of visits, infants had one or more sign of systemic infection, while 25% had fast breathing in 7-59 days period and 23% had a local infection. All signs of infection, including multiple signs, were more frequently seen in the first week of life. The risk of mortality was very low (0.2%) for local infections and fast breathing in 7-59 days old, it was low for fast breathing 0-6 days old (0.6%), high body temperature (0.7%) and severe chest indrawing (1.0%), moderate for low body temperature (4.9%) and stopped feeding well/not able to feed at all (5.0%) and high for movement only when stimulated or no movement at all (10%) and multiple signs of systemic infection (15.5%). The risk of death associated with most clinical signs was higher (1.5 to 9 times) in the first week of life than at later age, except for low body temperature (4 times lower) as well as high body temperature (2 times lower). Signs of infections are common in the first two months of life. The mortality risk differs with clinical signs and can be grouped as very low (local infections, fast breathing 7-59 days), low (fever, severe chest indrawing and fast breathing 0-6 days), moderate (low body temperature and stopped feeding well/not able to feed at all) and high (for movements only on stimulation or no movements at all and multiple signs of infection). New treatment strategies that consider differential mortality risk could be developed and evaluated based on these findings. The trial was registered with Australian New Zealand Clinical Trials Registry under ID ACTRN 12610000286044.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>33626090</pmid><doi>10.1371/journal.pone.0247457</doi><tpages>e0247457</tpages><orcidid>https://orcid.org/0000-0002-9720-5699</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2021-02, Vol.16 (2), p.e0247457-e0247457
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2492989950
source DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Adolescents
Age
Aging
Bacterial diseases
Bacterial infections
Biology and Life Sciences
Body temperature
Children
Childrens health
Data analysis
Demographic aspects
Diagnosis
Direct reduction
Editing
Fatalities
Fever
Health risks
Health surveillance
Hospitals
Infants
Infections
Medicine
Medicine and Health Sciences
Meta-analysis
Methodology
Mortality
Mortality risk
Neonates
Newborn babies
Patient outcomes
Pediatrics
People and Places
Public health
Sepsis
Signs
title Prevalence of clinical signs of possible serious bacterial infection and mortality associated with them from population-based surveillance of young infants from birth to 2 months of age
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T04%3A17%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20clinical%20signs%20of%20possible%20serious%20bacterial%20infection%20and%20mortality%20associated%20with%20them%20from%20population-based%20surveillance%20of%20young%20infants%20from%20birth%20to%202%20months%20of%20age&rft.jtitle=PloS%20one&rft.au=Puri,%20Dhruv&rft.date=2021-02-24&rft.volume=16&rft.issue=2&rft.spage=e0247457&rft.epage=e0247457&rft.pages=e0247457-e0247457&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0247457&rft_dat=%3Cgale_plos_%3EA652924360%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2492989950&rft_id=info:pmid/33626090&rft_galeid=A652924360&rft_doaj_id=oai_doaj_org_article_87b2e781cea64fdb9ea0e7d5d7d83db3&rfr_iscdi=true